The shortlist of Boston-area tech companies on deck for an initial public offering got shorter after Monday’s announcement that Veracode has agreed to be sold to CA Technologies for $614 million in cash.
The 11-year-old Veracode, which helps businesses secure... Read more »
In one of the biggest tech acquisitions of the year to date, Veracode is getting bought by CA Technologies for $614 million in cash. The deal is expected to close next month.
Veracode had raised more than $100 million in venture... Read more »
[Corrected, 3/7/17, 9:56am. See below] At the MIT Sloan Sports Analytics Conference in Boston last Friday, the NBA’s senior vice president of digital media, Melissa Brenner, got bullish on the potential for augmented reality inside NBA arenas. She was... Read more »
Activist investors challenging the management of Immunomedics have reportedly won control of a majority of the seats on the drug developer’s board of directors, putting another hurdle in front of a deal to license the company’s lead drug to Seattle Genetics.... Read more »
In an address to Congress this week, President Donald Trump outlined many of his near-term goals, including an overhaul of the Affordable Care Act, also known as Obamacare, even as public opinion has begun to shift in favor of the law.... Read more »
In the venture capital business, a rising tide lifts all boats.
That’s the idea, at least. A new report released today by Seattle-based PitchBook shows that U.S. venture firms have plenty of capital to invest in new companies, after 328 venture... Read more »
Snap, which rose to unicorn status based on a social media app that creates quickly vanishing photos, attracted solid investor interest in an IPO that raised $3.4 billion and sent shares up more than 50 percent above the initial offering price... Read more »
Examity, which offers remote proctoring services for tests that students take online, has received a $21 million investment.
The money comes from two New York-based investment firms, University Ventures and Inherent Group, according to a press release e-mailed to Xconomy. The... Read more »
San Antonio — Evestra, an early stage drug developer focused on women’s health, has made a deal with the U.S. division of Mumbai-based Glenmark Pharmaceuticals to try to bring its generic version of the NuvaRing birth control product to market.
San... Read more »